terarecon logo
Free Trial

Customer Services 

Learning Center

About Us
terarecon logo
Free Trial

Customer Services 

Learning Center

About Us

    News

    ConcertAI’s TeraRecon Receives ISO 27001 Certification

    ConcertAI's TeraRecon adds Prostate Cancer Detection/Diagnosis into Eureka Clinical AI Platform with Bot Image, Inc. Partnership

    ConcertAI’s TeraRecon Advances Cardiovascular Visualization with the Launch of Intuition 4.7

    ConcertAI's TeraRecon Expands AI Model and Clinical Collaboration Capabilities of Eureka Clinical AI

    ConcertAI's TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders

    Combinostics Partnership with ConcertAI's TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI

    Infervision Partnership with ConcertAI's TeraRecon brings their Lung CT.AI to Eureka Clinical AI

    Cercare Medical brings their Neurovascular Clinical Workflows into ConcertAI's TeraRecon Eureka Clinical AI Platform in new Partnership

    ConcertAI's TeraRecon Brings Osteoarthritis and Fracture Detection to the Eureka Clinical AI Platform with Radiobotics Partnership

    ConcertAI's TeraRecon adds AI-based oncology contouring capabilities into the Eureka Clinical AI Platform with Coreline Soft Partnership

    ConcertAI's TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism

    ConcertAI's TeraRecon Inks Distribution Deals with Seven AI Developers Alongside EU Launch of Eureka Clinical AI Platform at #ECR23

    ConcertAI's TeraRecon, in Us2 AI Partnership, Integrates AI-Enabled Echocardiography Decision Support into Eureka Clinical AI Platform

    ConcertAI's TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership

    ConcertAI's TeraRecon Expands AI, Partner, and Advanced Imaging Solutions at #RSNA22, Helping Clinicians Improve Efficiency and Care with Next Generation Eureka Clinical AI Platform

    ConcertAI's TeraRecon Brings Neuro-oncology Imaging into the Eureka Clinical AI Platform with Imaging Biometrics Partnership

    TeraRecon Announces Launch of its Next Generation Eureka Clinical AI Platform

    ConcertAI's TeraRecon Releases AI-Assisted Clinical Workflow Solution, TeraRecon Neuro

    ConcertAI’s TeraRecon Accelerates Multi-Specialty Advanced Visualization Capabilities with the Launch of Intuition 4.6

    TeraRecon Announces DocPanel Signs Contract for Intuition Titanium, Reaffirming its Cardiothoracic Imaging Service Commitment

    ConcertAI Announces Integration of TeraRecon, Accelerating Enterprise AI Deployment into Clinical Practice and Broadening Precision Oncology Research Network

    SymphonyAI Company TeraRecon Appoints Dan McSweeney President

    TeraRecon Appoints Sinan Batman CTO

    TeraRecon Expands Distribution to Brazil with KLAS Leading PACS provider, Pixeon

    TeraRecon CEO Jeff Sorenson To Depart, Dr. Romesh Wadhwani To Serve As Interim CEO

    TeraRecon Expands Change Healthcare Distribution Agreement Adding AI Subscription

    TeraRecon Launches NVIDIA-Powered Clinical Training Cloud for Global Education

    TeraRecon Awarded Landmark Patent for Diagnostic Imaging Clinical Reporting with AI

    TeraRecon Launches Intuition Subscription with Included Eureka AI Platform

    TeraRecon AI Products Adopt SymphonyAI Eureka Brand Recognizing AI Technology Synergies

    TeraRecon Adds Top Industry Leaders to Accelerate Next Phase of Growth

    SymphonyAI Group Acquires Healthcare Imaging AI Technology Leader TeraRecon

    TeraRecon Awarded Two AI Platform Patents

    TeraRecon Unveils New AI Key-Workflow Subscription Offerings

    TeraRecon Debuts New AI Sync™ Technology

    TeraRecon Unveils Intuition AI Data Extractor

    TeraRecon Receives First-of-Kind FDA Determination

    EnvoyAI Made Available to Over 200 UK Healthcare Locations

    Teleradiology Innovator, DocPanel, Selects TeraRecon for Advanced Visualization and Artificial Intelligence Technologies

    TeraRecon Achieves #1 Advanced Visualization Market Share – Extends Technology Reach with Broad PACS Distribution and Integration

    TeraRecon Spinoff EnvoyAI Named Best New Radiology Vendor in 2018 Minnies awards

    EnvoyAI Partners with Mach7 Technologies to expand AI to Enterprise Imaging, VNA, and PACS

    TeraRecon Debuts Next Generation Northstar™ AI Explorer at SIIM18

    Wake Radiology Launches EnvoyAI Platform in First-of-Kind Implementation

    EnvoyAI, TeraRecon, and Insignia Partner to bring Artificial Intelligence to United Kingdom Customers

    TeraRecon is First to Pass Stringent New US Department of Defense Security Requirements

    EnvoyAI, Ambra Health, and TeraRecon Deliver First End-to-End AI Strategy

    RSNA17 AI Bone Age Challenge Champion, 16 Bit, Offers Award-Winning Algorithm on EnvoyAI Platform Free for Research Use

    TeraRecon launches EnvoyAI distributorship to resell the 35+ algorithms on the EnvoyAI Exchange

    TeraRecon Announces Major Intuition Release

    TeraRecon acquires McCoy Medical Technologies and spins out a new AI platform company

    TeraRecon Japan Announces Partnership with CV Imaging Science and CVIC

    TeraRecon Demonstrates Deep Learning Workflow at HIMSS17

    TeraRecon Delivers Virtualization Upgrade with VP CUDA

    TeraRecon announces the release of an advanced integration with Agfa

    UK’s Largest Teleradiology Group, MEDICA, Selects TeraRecon

    ­TeraRecon Appoints Sorenson CEO and Accelerates R&D Investment

    Content not found

    About TeraRecon

    TeraRecon is a leader in advanced visualization, artificial intelligence, image viewing, and post-processing.

    Learn More →

    Subscribe to Receive News Updates

    TeraRecon, Inc

    TeraRecon Headquarters
    4309 Emperor Blvd, Suite 310
    Durham, NC 27703 
    Tel: 650.372.1100
    Fax: 650.372.1101
    info@terarecon.com 

    Additional Resources

    Subscribe to our newsletter

    ©2016-2022 Terarecon, Inc. All Rights Reserved.